Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1999-07-08
2000-01-25
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514647, A61K 31195, A61K 31135
Patent
active
060179619
ABSTRACT:
The present invention relates to a novel ointment combining Ketamine and n-butyl-p-aminobenzoate (BAB) that is self-administered topically by a subject to alleviate Neuropathic pain, Sympathetic Mediated pain, TMJ pain, SIJ pain and Osteoarthritic pain said subject is experiencing. The present invention is an improvement over the Ketamine only based ointment disclosed in U.S. Pat. No. 5,817,699.
REFERENCES:
patent: 4599354 (1986-07-01), Shulman
patent: 5817699 (1998-10-01), Flores et al.
Crowley Kenton Lance
Flores John Anthony
Henley III Raymond
Phillips Rob L.
LandOfFree
Ketamine and n-butyl-p-aminobezoate in PLO does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ketamine and n-butyl-p-aminobezoate in PLO, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ketamine and n-butyl-p-aminobezoate in PLO will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2316329